Email Us
View Reports

Infectious Disease Therapeutics Market

Infectious Disease Therapeutics Market Analysis – By Type: (HIV infection, Influenza, Malaria, Tuberculosis, Hepatitis, HPV infection), By Application (Hospital, Clinic, Research Institute, Laboratories), By Regional – Global Industry Size, Growth, Share, Trends, Demand, Strategy and Competitive Analysis Forecast Report to 2023.

  • ID : 2964923  |  
  • Published : Apr-2018  |  
  • Region : Global  |  
  • Pages : 94   |  
  • Publisher : QY Research

Infectious Disease Therapeutics Market Overview:

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, parasites. These diseases can be transmitted to each other by direct or indirect contact. Anti-infective medications are used to inhibit the growth of the disease. These medications can work through the host defense system and can be directed to the responsible agent. Worldwide, infectious diseases such as malaria, HIV, tuberculosis, influenza, hepatitis A and hepatitis C pose serious public health problems. These diseases are, therefore, the leading cause of death in the world.

Infectious Disease Therapeutics Market worth USD 105.13 Billion in 2018 and estimated to reach USD 154.18 Billion by the end of 2023 with a growing CAGR of 7.96 %.

Infectious Disease Therapeutics Market Drivers and Restraints:

The main factors driving market growth are the proliferation of infectious diseases, the increasing use of direct-acting antivirals, the rise in health care expenditures, the growth in the geriatric population, the increase in health awareness and augmenting public funds in developing countries. The main factor that hinders the growth of the market is the generic erosion, and the expiration of the patents of medicines against infectious diseases.

Infectious Disease Therapeutics Market Geographical Analysis:

North America is expected to represent the largest proportion of the market, followed by the Asia-Pacific region and Europe due to the increasing incidence of infectious diseases and the aging of the population. The Asia-Pacific region is expected to register the highest compound annual growth rate during the review period due to increased government funding in its emerging countries such as India and China.

Despite the increase in control measures, many infectious diseases are emerging, reappearing or causing recurrent outbreaks, particularly in the Asia-Pacific region. The most developed countries in the Asia-Pacific region, such as Japan and Australia, have a strong history of fighting infectious diseases, although the prevalence of infectious diseases in this region is high.

The health service delivery system in the Asia-Pacific region, the majority financed by private funds, is the most prone to economic recessions, although it is partially offset by the fact that much of traditional medicine. China is the largest market for the infectious disease therapies market in Asia-Pacific, accounting for 27% of the market in 2016.

Prominent Players Covered in this Infectious Disease Therapeutics Market Report are:

  • Novartis AG

  • Gilead

  • GlaxoSmithKline plc
  • Janssen Pharmaceutical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • BioCryst Pharmaceuticals, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim GmbH

Global Infectious Disease Therapeutics Market Key Segmentation Analysis:

Infectious Disease Therapeutics Market segment by Type, the product can be split into

  • HIV infection
  • Influenza
  • Malaria
  • Tuberculosis
  • Hepatitis
  • HPV infection

Infectious Disease Therapeutics Market segment by Application, Infectious Disease Therapeutics can be split into

  • Hospital
  • Clinic
  • Research Institute
  • Laboratories

Infectious Disease Therapeutics Market segment by Regions/Countries, this report covers

  • North America
  • Asia-Pacific
  • Europe
  • Central & South America
  • Middle East & Africa

Table of Contents:

  1. Introduction                                                                      
  2. Research Methodology                                                                   

    1. Analysis Design                                             

      1. Research Phases                                                            
      2. Secondary Research                                  
      3. Primary Research                                      
      4. Expert Validation                                       

    2. Study Timeline                                                

  3. Overview                                                                         

    1. Executive Summary                                                                 
    2. Key Inferences                                                
    3. New Developments                                                      

  4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                             

    1. Global Infectious Disease Therapeutics Market Drivers                                                
    2. Global Infectious Disease Therapeutics Market Restraints                                                         
    3. Key Challenges                                               
    4. Current Opportunities in the Global Infectious Disease Therapeutics Market

  5. Global Infectious Disease Therapeutics Market Segmentation                                                                    

    1. By Type

      1. HIV infection
      2. Influenza
      3. Malaria
      4. Tuberculosis
      5. Hepatitis
      6. HPV infection

    2. By Application

      1. Hospital
      2. Clinic
      3. Research Institute
      4. Laboratories

  6. Geographical Analysis                                                                    

    1. North America

      1. United States
      2. Canada
      3. Mexico

    2. Asia-Pacific

      1. China
      2. India
      3. Japan
      4. South Korea
      5. Australia
      6. Indonesia
      7. Singapore
      8. Rest of Asia-Pacific

    3. Europe

      1. Germany
      2. France
      3. UK
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe

    4. Central & South America

      1. Brazil
      2. Argentina
      3. Rest of South America

    5. Middle East & Africa

      1. Saudi Arabia
      2. Turkey
      3. Rest of Middle East & Africa

  7. Strategic Analysis                                                            

    1. PESTLE analysis                                             

      1. Political                                     
      2. Economic                                   
      3. Social                                          
      4. Technological                             
      5. Legal                                          
      6. Environmental                                            

    2. Porter’s five analysis                                                    

      1. Bargaining Power of Suppliers                                  
      2. Bargaining Power of Consumers                               
      3. Threat of New Entrants                             
      4. Threat of Substitute Products and Services                               
      5. Competitive Rivalry within the Industry          

    3. Supply Chain Analysis

      1. Raw Material Suppliers
      2. Manufacturers/Producers
      3. Distributors/Retailers/Wholesalers/E-Commerce
      4. End Users

  8. Global Infectious Disease Therapeutics Market Leaders' Analysis      

    1. Novartis AG

      1. Product Analysis                                        
      2. Strategic Evaluation and Operations                                          
      3. Financial analysis                                        
      4. Legal issues                                
      5. Recent Developments                               
      6. SWOT analysis                                           
      7. Analyst View      

    2. Gilead
    3. GlaxoSmithKline plc
    4. Janssen Pharmaceutical, Inc.
    5. F. Hoffmann-La Roche Ltd.
    6. BioCryst Pharmaceuticals, Inc.
    7. Merck & Co., Inc.
    8. Boehringer Ingelheim GmbH

  9. Competitive Landscape                                                                   

    1. Global Infectious Disease Therapeutics Market share analysis                                                    
    2. Merger and Acquisition Analysis                                                  
    3. Agreements, collaborations and Joint Ventures                                                          
    4. New Product Launches                                                  

  10. Expert Opinions                                                            

    1. Global Infectious Disease Therapeutics Market Outlook                                                            
    2. Investment Opportunities                                                           

  11. Appendix                                                             

    1. List of Tables                          
    2. List of Figurers

List of Tables and Figures

Figure Global Infectious Disease Therapeutics Market Size (Million USD) Status and Outlook (2013-2018)

Table Global Infectious Disease Therapeutics Revenue (Million USD) Comparison by Regions (2013-2018)

Figure Global Infectious Disease Therapeutics Market Share by Regions (2013-2018)

Figure United States Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure EU Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Japan Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure China Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure India Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Figure Southeast Asia Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate by Regions (2013-2018)

Table Global Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (%) Comparison by Product (2013-2018)

Figure Global Infectious Disease Therapeutics Revenue Market Share by Type in 2017

Figure HIV infection Market Size (Million USD) and Growth Rate (2013-2018)

Figure Influenza Market Size (Million USD) and Growth Rate (2013-2018)

Figure Malaria Market Size (Million USD) and Growth Rate (2013-2018)

Figure Tuberculosis Market Size (Million USD) and Growth Rate (2013-2018)

Figure Hepatitis Market Size (Million USD) and Growth Rate (2013-2018)

Figure HPV infection Market Size (Million USD) and Growth Rate (2013-2018)

Figure Global Infectious Disease Therapeutics Market Share by Application in 2017

Figure Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate in Hospital (2013-2018)

Figure Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate in Clinic (2013-2018)

Figure Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate in Research Institute (2013-2018)

Figure Infectious Disease Therapeutics Market Size (Million USD) and Growth Rate in Laboratories (2013-2018)

Table Infectious Disease Therapeutics Market Size (Million USD) by Players (2013-2018)

Figure Infectious Disease Therapeutics Market Size Share by Players in 2013

Figure Infectious Disease Therapeutics Market Size Share by Players in 2017

Table Novartis AG Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of Novartis AG (2013-2018)

Figure Novartis AG Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table Gilead Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of Gilead (2013-2018)

Figure Gilead Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table GlaxoSmithKline plc Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of GlaxoSmithKline plc (2013-2018)

Figure GlaxoSmithKline plc Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table Janssen Pharmaceutical, Inc. Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of Janssen Pharmaceutical, Inc. (2013-2018)

Figure Janssen Pharmaceutical, Inc. Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table F. Hoffmann-La Roche Ltd. Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of F. Hoffmann-La Roche Ltd. (2013-2018)

Figure F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table BioCryst Pharmaceuticals, Inc. Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of BioCryst Pharmaceuticals, Inc. (2013-2018)

Figure BioCryst Pharmaceuticals, Inc. Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table Merck & Co., Inc. Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of Merck & Co., Inc. (2013-2018)

Figure Merck & Co., Inc. Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table Boehringer Ingelheim GmbH Basic Information List

Table Infectious Disease Therapeutics Business Revenue (Million USD) of Boehringer Ingelheim GmbH (2013-2018)

Figure Boehringer Ingelheim GmbH Infectious Disease Therapeutics Business Revenue Market Share (2013-2018)

Table Global Infectious Disease Therapeutics Market Size (Million USD) by Product (2013-2018)

Figure Global Infectious Disease Therapeutics Revenue Market Share (%) by Product (2013-2018)

Figure Global Infectious Disease Therapeutics Market Share by Product in 2017

Table Global Infectious Diseand Growth Rate (2018-2025)

Figure India Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)

Figure Southeast Asia Infectious Disease Therapeutics Revenue (Million USD) and Growth Rate (2018-2025)

Table Global Infectious Disease Therapeutics Market Size (Million USD) by Type (2018-2025)

Figure Global Infectious Disease Therapeutics Market Size Share by Type in 2018

Figure Global Infectious Disease Therapeutics Market Size Share by Type in 2025

Table Global Infectious Disease Therapeutics Market Size (Million USD) by Application (2018-2025)

Figure Global Infectious Disease Therapeutics Market Size (Million USD) by Application in 2018

Figure Global Infectious Disease Therapeutics Market Size (Million USD) by Application in 2025

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?